Engineering next-generation, brain-penetrant cancer therapies.
Many cancer therapies cannot effectively reach or treat tumors in the brain due to limited brain penetration.
It engineers next-generation cancer therapeutics designed to penetrate the brain and treat brain tumors or metastases.
Pharmaceutical and biotech companies developing oncology drugs and clinicians treating patients with brain cancers.




